Levofloxacin
Brand names: Tavanic
Levofloxacin is a fluoroquinolone antibiotic reserved for serious or resistant infections such as pneumonia, complicated urinary tract and intra-abdominal infections where other antibiotics are unsuitable.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, blocking DNA replication and transcription, producing a bactericidal effect.
Prescribing in practice
- MHRA warns of disabling and potentially long-lasting or irreversible musculoskeletal and nervous system effects, including tendon rupture and aortic aneurysm or dissection, so reserve fluoroquinolones and stop at the first sign of tendon pain.
- It can prolong the QT interval, so use caution with other QT-prolonging drugs and in electrolyte disturbance.
- Absorption is reduced by calcium, iron, zinc and antacids, and it lowers the seizure threshold.
Monitoring
There is no routine laboratory monitoring, but observe for tendon, neurological and cardiac adverse effects and stop promptly if they occur.
Counselling the patient
- Stop and seek advice if you develop tendon pain or swelling, new numbness or tingling, or significant mood changes.
- Separate from indigestion remedies and iron or calcium supplements, and avoid excessive sun exposure.
- Report palpitations or fainting.
Evidence & guidelines
MHRA fluoroquinolone safety reviews restrict levofloxacin to situations where other antibiotics cannot be used, reflected in NICE antimicrobial prescribing guidance.
Reference: MHRA Drug Safety Update 2019 (Fluoroquinolone Antibiotics); NICE NG138 (Pneumonia); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia